Allocation of donor livers - Is MELD enough?

Liver Transplantation

Volumn 10, Issue 7, 2004, Pages 908-910

  Neuberger, James ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC LIVER DISEASE; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; EDITORIAL; GRAFT FAILURE; GRAFT SURVIVAL; HEALTH CARE DELIVERY; HUMAN; LABORATORY TEST; LIVER FAILURE; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; MEDICAL ETHICS; ORGAN DONOR; OUTCOMES RESEARCH; PORTOSYSTEMIC ANASTOMOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RECIPIENT; RESOURCE ALLOCATION; SCORING SYSTEM; SURVIVAL RATE;

HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; PROGNOSIS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 3242758269     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20166     Document Type: Editorial

References (18)

1. Wang VS, Saab S. Liver transplantation in the era of model for end-stage liver disease. Liver Int 2004;24:1-8.
2. Yao FY, Saab S, Bass NM, Hirose R, Ly D, Terrault N, et al. Prediction of survival after liver retransplantation for late graft failure based on preoperative prognostic scores. Hepatology 2004;39:230-238.
3. Hayashi PH, Trotter JF, Forman L, Kugelmas M, Steinberg T, Russ Wachs M, et al. Impact of pretransplant diagnosis of hepatocellular carcinoma on cadaveric liver allocation in the era of MELD. Liver Transpl 2004;10:42-48.
4. Saab S, Wang V, Ibrahim AB, Durazo F, Han S, Farmer DG, et al. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl 2003;9:473-476.
5. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl 2004;10:36-41.
6. Adam R, Cailliez V, Majno P, Karam V, McMaster P, Calne RY, et al. Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet 2001;356: 621-627.
7. Freeman B, Wiesner RH, Edwards E, Harper A, Merion RM, Wolfe R and the UNOS/OPTN Liver and Intestine Transplantation Committee. Results of the first year of the new liver allocation plan. Liver Transpl 2004;10:7-15.
8. Brown RS, Kumar KS, Russo MW, Kinkhabwala M, Rudow DL, Harren P, et al. Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplant disease severity, posttransplantation and outcome and resource utilisation in United Network for Organ Sharing status 2A patients. Liver Transpl 2002;8:278-284.
9. Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmans M, et al. Model for end-stage liver disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl 2002;9:737-740.
10. Rosen HR, Prieto M, Casanovas-Taltavull T, Cueervas-Mons V, Guckelberger O, Muiesan P, et al. Validation and refinement of survival models for liver re-transplantation. Hepatology 2003; 38:460-469.
11. Yoo HY, Edwin D, Thuluvath PJ. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, neuropsychiatric testing and ascites. Am J Gastroenterol 2003; 98:1395-1398.
12. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United states: a disease-specific analysis of the UNOS database. Liver Transpl 2004;10: 886-897.
13. Jacob AM, Copley LP, Lewsey JD, Gimson A, Toogood GJ, Rela M, Van der Meulen JHP. Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl 2004;10:903-907.
14. Stell D, McAlister VC, Thorburn D. A comparison of disease severity and survival rates after liver transplantation in the United Kingdom, Canada and the United States. Liver Transpl 2004; 10:898-902.
15. Desai NM, Mange KC, Crawford MD, Abt PL, Frank AM, Markmann JW, et al. Predicting outcome after liver transplantation: utility of the model for end-stage liver disease and a newly derived discrimination function. Transplantation 2004;77:99-106.
16. Neuberger J, James OFW. Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage. Lancet 1999;354:1636-1639.
17. Kremers WK, Van Ijparen M, Kim WR, Freeman RB, Harper AM, Kamath PS, Wiesner RH. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology 2004;39:764-769.
18. Onaca NN, Levy MF, Sanchez EQ, Chinnakotla S, Fasola CG, Thomas MJ, et al. A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation. Liver Transpl 2003;9:124-125.